LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Aperta

SettoreSettore sanitario

21.4 0.9

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.65

Massimo

21.41

Metriche Chiave

By Trading Economics

Entrata

-5.7M

-12M

Vendite

-2.8M

73M

EPS

0.04

Margine di Profitto

-16.197

Dipendenti

1,313

EBITDA

-2M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+15.27% upside

Dividendi

By Dow Jones

Utili prossimi

1 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

57M

629M

Apertura precedente

20.5

Chiusura precedente

21.4

Notizie sul Sentiment di mercato

By Acuity

78%

22%

357 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Fulgent Genetics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 giu 2025, 20:45 UTC

Utili

Broadcom 2Q Sales Climb on Booming AI Demand

5 giu 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 giu 2025, 23:44 UTC

Discorsi di Mercato

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 giu 2025, 23:30 UTC

Discorsi di Mercato

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 giu 2025, 21:32 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

5 giu 2025, 20:45 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:24 UTC

Utili

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Rev $15B >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Net $4.97B >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q Adj EPS $1.58 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom 2Q EPS $1.03 >AVGO

5 giu 2025, 20:15 UTC

Utili

Broadcom Sees 3Q Rev $15.8B >AVGO

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 giu 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 giu 2025, 19:22 UTC

Discorsi di Mercato

Oil Futures Resume Upward Moves -- Market Talk

5 giu 2025, 19:00 UTC

Discorsi di Mercato

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 giu 2025, 18:32 UTC

Discorsi di Mercato

Gold Slips After Trump-Xi Call -- Market Talk

5 giu 2025, 18:26 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 giu 2025, 18:06 UTC

Discorsi di Mercato

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 giu 2025, 16:30 UTC

Acquisizioni, Fusioni, Takeovers

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 giu 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

5 giu 2025, 16:18 UTC

Discorsi di Mercato

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 giu 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

5 giu 2025, 16:12 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

5 giu 2025, 16:12 UTC

Discorsi di Mercato

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 giu 2025, 16:03 UTC

Discorsi di Mercato

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 giu 2025, 15:49 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Fulgent Genetics Inc Previsione

Obiettivo di Prezzo

By TipRanks

15.27% in crescita

Previsioni per 12 mesi

Media 24 USD  15.27%

Alto 25 USD

Basso 23 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fulgent Genetics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

1

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

17.32 / 19.04Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Neutral Evidence

Sentiment

By Acuity

357 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.